Australian middle-market private equity firm CPE has agreed to sell Cell Care, its cord blood banking business, to Generate Life Sciences, an American life sciences firm, for an undisclosed amount.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
